← Browse by Condition
Medical Condition

metastatic pancreatic neuroendocrine tumor

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05687123 Phase 1
Recruiting

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Enrollment
24 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
View Trial →